Autolus Therapeutics annual debt-to-assets ratio
2017
2018
2019
2020
2021
2022
2023
2024
2025
Autolus Therapeutics Debt-to-Assets Ratio Growth & History (AUTL)
Autolus Therapeutics's debt-to-assets ratio was 0.12 for fiscal 2025.
View full Autolus Therapeutics company overviewAutolus Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.12 | 0.05 | +80.23% |
| 2024 | 2024-12-31 | 0.07 | −0.07 | −52.35% |
| 2023 | 2023-12-31 | 0.14 | 0.09 | +185.20% |
| 2022 | 2022-12-31 | 0.05 | −0.00 | −4.44% |
| 2021 | 2021-12-31 | 0.05 | −0.13 | −71.87% |
| 2020 | 2020-12-31 | 0.18 | 0.10 | +113.08% |
| 2019 | 2019-12-31 | 0.09 | — | — |
| 2018 | 2018-09-30 | 0.00 | −0.00 | −72.90% |
| 2017 · Sep 30 | 2017-09-30 | 0.01 | — | — |
Autolus Therapeutics quarterly debt-to-assets ratio
Q4.17
Q4.18
Q1.19
Q3.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q4.21
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.17 | 0.08 | +89.16% |
| Q1 2026 | 2026-03-31 | 0.15 | 0.07 | +96.19% |
| Q4 2025 | 2025-12-31 | 0.12 | 0.05 | +80.23% |
| Q3 2025 | 2025-09-30 | 0.10 | 0.04 | +57.57% |
| Q2 2025 | 2025-06-30 | 0.09 | 0.03 | +52.75% |
| Q1 2025 | 2025-03-31 | 0.08 | 0.02 | +35.77% |
| Q4 2024 | 2024-12-31 | 0.07 | −0.07 | −52.35% |
| Q3 2024 | 2024-09-30 | 0.06 | −0.07 | −51.14% |
| Q2 2024 | 2024-06-30 | 0.06 | — | — |
| Q1 2024 | 2024-03-31 | 0.06 | — | — |
| Q4 2023 | 2023-12-31 | 0.14 | 0.09 | +185.20% |
| Q3 2023 | 2023-09-30 | 0.13 | — | — |
| Q4 2022 | 2022-12-31 | 0.05 | −0.00 | −4.44% |
| Q4 2021 | 2021-12-31 | 0.05 | −0.13 | −71.87% |
| Q1 2021 | 2021-03-31 | 0.07 | −0.01 | −15.84% |
| Q4 2020 | 2020-12-31 | 0.18 | 0.10 | +113.08% |
| Q3 2020 | 2020-09-30 | 0.17 | 0.08 | +96.35% |
| Q2 2020 | 2020-06-30 | 0.09 | 0.01 | +14.19% |
| Q1 2020 | 2020-03-31 | 0.08 | — | — |
| Q4 2019 | 2019-12-31 | 0.09 | 0.09 | +7605.33% |
| Q3 2019 · Sep 30 | 2019-09-30 | 0.08 | 0.08 | +6005.34% |
| Q3 2019 · Jun 30 | 2019-06-30 | 0.08 | — | — |
| Q1 2019 | 2018-12-31 | 0.00 | — | — |
| Q4 2018 | 2018-09-30 | 0.00 | −0.00 | −72.90% |
| Q4 2017 · Sep 30 | 2017-09-30 | 0.01 | — | — |
Autolus Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, Autolus Therapeutics's debt-to-assets ratio decreased from 0.18 to 0.12, a change of −0.06. The latest reported quarter, Q2 2026, shows 0.17.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Autolus Therapeutics source filings ↗